Physicians' Academy for Cardiovascular Education

VBG Hangzhou

Exploring gold standards for lipid management in CHD, Diabetes & Stroke

Apr. 23, 2010

Exploring gold standards for lipid management in CHD, Diabetes & Stroke

Teaching slides from a Vascular Biology Meeting providing a forum for the review, exchange, and assimilation of findings from vascular biology research for dissemination to the clinical medicine community with a focus on lipid management held on April 24-25 2010 in Hangzhou, China

The resources are for educational purposes only. Click on the slides to review

Teaching slides from a Vascular Biology Meeting providing a forum for the review, exchange, and assimilation of findings from vascular biology research for dissemination to the clinical medicine community with a focus on lipid management

Prevention of stroke

What is the rationale and evidence for lipid intervention
Henrik Sillesen, MD
Rigshospitalet, University of Copenhagen Copenhagen
Denmark

Diabetes & vascular risk

Opportunities for lipid management
Ronald Ma, MD
The Chinese University of Hong Kong,
Hong Kong

Atherosclerosis in the early stages of CHD

Mechanisms and opportunities for lipid intervention

John E. Deanfield, MD, Bchir
University College London,
London, UK

Managing the late consequences of CHD

What is the evidence for lipid management
Andrew Selwyn, MD
Brigham and Womens Hopsital
Harvard Medical School
Boston, USA

Practical lipid management:

What about dosing and switching?
Peter Lansberg, MD
Academic Medical Centre,
Amsterdam, The Netherlands

Atherosclerosis in CHD

Atherosclerosis in the early stages of CHD; Mechanisms and opportunities for lipid intervention
John E. Deanfield, MD, Bchir, University College London, United Kingdom

Lipid Management

Practical lipid management:What about dosing and switching?
Peter Lansberg, MD Academic Medical Centre,  Amsterdam, The Netherlands

Prevention of stroke

What is the rationale and evidence for lipid intervention
Henrik Sillesen, MD, Rigshospitalet, University of Copenhagen Copenhagen, Denmark

Managing CHD

Managing the late consequences of CHD: What is the evidence for lipid management?
Andrew Selwyn, MD, Brigham and Womens Hopsital, Harvard Medical School, Boston, USA

Diabetes & vascular risk:

Opportunities for lipid management, Ronald Ma, MD, The Chinese University of Hong Kong, in discussion with prof John Deanfield



The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: